Novartis can’t amend complaint, seek US jury trial in generic drug battle with MSN Pharmaceuticals
Importation in August by India’s MSN Pharmaceuticals of 300,000 bottles of sacubitril/valsartan tablets to US subsidiary Novadoz wasn't enough to convince a US judge to convert litigation over MSN’s recently-approved generic...To view the full article, register now.
Already a subscriber? Click here to view full article